MedTrace Logo

Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

NCT00463840 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-12-05

Study results available
· View outcomes & findings →

Summary

The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.

Conditions

Interventions

DRUG

Oxaliplatin

DRUG

5FU

RADIATION

Radiation

PROCEDURE

Surgery

DRUG

FOLFOX 6

this is an established regimen of Oxaliplatin+infusional 5FU/Leucovorin

Sponsors & Collaborators

Principal Investigators

  • Theresa Ryan, MD · NYU Langone Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2010-07-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463840 on ClinicalTrials.gov